Using Biosimulation to Develop Pediatric Therapeutics

Updated: Apr 3

An Empowered Patient Podcast


Using Biosimulation to Develop Pediatric Therapeutics with Lynne Georgopoulos of Certara

on Empowered Patient Podcast, hosted by Karen Jagoda


Lynne Georgopoulos, VP Regulatory Strategy, Certara describes the company's platform to optimize pediatric drug development using biosimulation.  With an eye on pediatric diseases, Certara is employing modeling and simulation to determine how a drug developed for adults may be metabolized in children, including neonates. They are also operationalizing clinical trials to be more efficient and potentially less invasive which is important when working with young children.


To listen to the podcast: https://empoweredpatientradio.com/using-biosimulation-to-develop-pediatric-therapeutics-with-lynne-georgopoulos-certara


Transcript of the podcast: https://empoweredpatientradio.com/using-biosimulation-to-develop-pediatric-therapeutics-with-lynne-georgopoulos-certara-transcript


Certara website: https://www.certara.com/


Empowered Patient website: https://www.empoweredpatientradio.com


Medical and Pharma Insider website: https://www.medicalandpharmainsider.com





Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887

Website: www.medicalandpharmainsider.com

Email mail@medicalandpharmainsider.com

MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2021 Medical and Pharma Insider and FC Global Strategies LLC